vs

Side-by-side financial comparison of Enovis CORP (ENOV) and Global-E Online Ltd. (GLBE). Click either name above to swap in a different company.

Global-E Online Ltd. is the larger business by last-quarter revenue ($625.5M vs $548.9M, roughly 1.1× Enovis CORP). Global-E Online Ltd. runs the higher net margin — 0.9% vs -104.1%, a 105.0% gap on every dollar of revenue.

Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Wilmington, Delaware and is listed on the NYSE as ENOV. The company has over 5,000 employees operating at 12 sites around the world.

Global-E Online Ltd. operates a leading cross-border e-commerce enablement platform that helps direct-to-consumer brands and retail enterprises expand their international sales reach. It offers end-to-end services including localized checkout, payment processing, customs clearance, logistics coordination, and duty calculation, serving clients across North America, Europe, and the Asia-Pacific region.

ENOV vs GLBE — Head-to-Head

Bigger by revenue
GLBE
GLBE
1.1× larger
GLBE
$625.5M
$548.9M
ENOV
Higher net margin
GLBE
GLBE
105.0% more per $
GLBE
0.9%
-104.1%
ENOV

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
ENOV
ENOV
GLBE
GLBE
Revenue
$548.9M
$625.5M
Net Profit
$-571.1M
$5.8M
Gross Margin
59.9%
45.0%
Operating Margin
-101.7%
1.3%
Net Margin
-104.1%
0.9%
Revenue YoY
-2.2%
Net Profit YoY
18.8%
EPS (diluted)
$-9.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ENOV
ENOV
GLBE
GLBE
Q4 25
$548.9M
Q3 25
$564.5M
$625.5M
Q2 25
$558.8M
$404.8M
Q1 25
$189.9M
Q4 24
$561.0M
Q3 24
$505.2M
$489.9M
Q2 24
$525.2M
$313.9M
Q1 24
$516.3M
$145.9M
Net Profit
ENOV
ENOV
GLBE
GLBE
Q4 25
$-571.1M
Q3 25
$-36.7M
$5.8M
Q2 25
$-56.0M
$-7.4M
Q1 25
Q4 24
$-703.2M
Q3 24
$-31.5M
$-77.1M
Q2 24
$-18.6M
$-54.5M
Q1 24
$-72.0M
Gross Margin
ENOV
ENOV
GLBE
GLBE
Q4 25
59.9%
Q3 25
59.3%
45.0%
Q2 25
59.5%
44.9%
Q1 25
44.3%
Q4 24
54.8%
Q3 24
56.7%
45.1%
Q2 24
55.0%
44.8%
Q1 24
57.7%
43.4%
Operating Margin
ENOV
ENOV
GLBE
GLBE
Q4 25
-101.7%
Q3 25
-3.0%
1.3%
Q2 25
-8.4%
-2.1%
Q1 25
-10.1%
Q4 24
-118.5%
Q3 24
-6.3%
-14.9%
Q2 24
-8.4%
-16.6%
Q1 24
-6.8%
-20.1%
Net Margin
ENOV
ENOV
GLBE
GLBE
Q4 25
-104.1%
Q3 25
-6.5%
0.9%
Q2 25
-10.0%
-1.8%
Q1 25
Q4 24
-125.4%
Q3 24
-6.2%
-15.7%
Q2 24
-3.5%
-17.4%
Q1 24
-13.9%
EPS (diluted)
ENOV
ENOV
GLBE
GLBE
Q4 25
$-9.99
Q3 25
$-0.64
Q2 25
$-0.98
Q1 25
Q4 24
$-12.69
Q3 24
$-0.58
Q2 24
$-0.34
Q1 24
$-1.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ENOV
ENOV
GLBE
GLBE
Cash + ST InvestmentsLiquidity on hand
$33.6M
$251.4M
Total DebtLower is stronger
$1.4B
Stockholders' EquityBook value
$2.0B
$933.0M
Total Assets
$4.4B
$1.3B
Debt / EquityLower = less leverage
0.67×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ENOV
ENOV
GLBE
GLBE
Q4 25
$33.6M
Q3 25
$44.1M
$251.4M
Q2 25
$38.5M
$205.2M
Q1 25
$207.7M
Q4 24
$48.2M
Q3 24
$35.4M
$207.3M
Q2 24
$35.0M
$229.8M
Q1 24
$66.3M
$181.9M
Total Debt
ENOV
ENOV
GLBE
GLBE
Q4 25
$1.4B
Q3 25
$1.4B
Q2 25
$1.4B
Q1 25
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.3B
Q1 24
$1.3B
Stockholders' Equity
ENOV
ENOV
GLBE
GLBE
Q4 25
$2.0B
Q3 25
$2.6B
$933.0M
Q2 25
$2.6B
$909.1M
Q1 25
$884.3M
Q4 24
$2.6B
Q3 24
$3.3B
$869.4M
Q2 24
$3.3B
$878.7M
Q1 24
$3.3B
$886.9M
Total Assets
ENOV
ENOV
GLBE
GLBE
Q4 25
$4.4B
Q3 25
$5.0B
$1.3B
Q2 25
$4.9B
$1.2B
Q1 25
$1.2B
Q4 24
$4.7B
Q3 24
$5.6B
$1.2B
Q2 24
$5.4B
$1.1B
Q1 24
$5.5B
$1.1B
Debt / Equity
ENOV
ENOV
GLBE
GLBE
Q4 25
0.67×
Q3 25
0.54×
Q2 25
0.53×
Q1 25
Q4 24
0.52×
Q3 24
0.40×
Q2 24
0.41×
Q1 24
0.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ENOV
ENOV
GLBE
GLBE
Operating Cash FlowLast quarter
$82.6M
Free Cash FlowOCF − Capex
$29.1M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
9.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$22.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ENOV
ENOV
GLBE
GLBE
Q4 25
$82.6M
Q3 25
$47.8M
Q2 25
$-1.6M
Q1 25
Q4 24
$88.3M
Q3 24
$53.6M
Q2 24
$7.8M
Q1 24
$-36.2M
Free Cash Flow
ENOV
ENOV
GLBE
GLBE
Q4 25
$29.1M
Q3 25
$3.4M
Q2 25
$-44.9M
Q1 25
Q4 24
$35.1M
Q3 24
$2.4M
Q2 24
$-31.6M
Q1 24
$-73.1M
FCF Margin
ENOV
ENOV
GLBE
GLBE
Q4 25
5.3%
Q3 25
0.6%
Q2 25
-8.0%
Q1 25
Q4 24
6.3%
Q3 24
0.5%
Q2 24
-6.0%
Q1 24
-14.2%
Capex Intensity
ENOV
ENOV
GLBE
GLBE
Q4 25
9.7%
Q3 25
7.9%
Q2 25
7.7%
Q1 25
Q4 24
9.5%
Q3 24
10.1%
Q2 24
7.5%
Q1 24
7.2%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ENOV
ENOV

Reconstructive Segment$258.0M47%
Surgical$129.0M23%
Prevention And Recovery$92.6M17%
Other Prevention And Recovery$71.4M13%

GLBE
GLBE

Segment breakdown not available.

Related Comparisons